Dormancy Stems the Tide of Chemotherapy
Deepali Pal1, Olaf Heidenreich1, Josef Vormoor1
1Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Level 6, Herschel Building, Brewery Lane, Newcastle upon Tyne NE1 7RU, UK.
Researchers identified rare, non-cycling blasts in acute lymphoblastic leukemia exhibiting dormancy, stemness, and chemo-resistance. This new model aids in understanding the leukemic microenvironment and developing targeted therapies.
Area of Science:
- Hematology
- Cancer Biology
- Cellular Biology
Background:
- Acute lymphoblastic leukemia (ALL) is a heterogeneous cancer.
- Understanding the biology of dormant leukemia cells is crucial for effective treatment.
- Chemo-resistance in ALL contributes to relapse and treatment failure.
Purpose of the Study:
- To characterize rare, non-cycling blasts in acute lymphoblastic leukemia (ALL).
- To investigate the phenotypes of dormancy, stemness, and chemo-resistance in these blasts.
- To establish a novel in vivo model for studying dormant ALL blasts.
Main Methods:
- In vivo modeling of dormant leukemia blasts.
- Phenotypic characterization of non-cycling ALL cells.
- Analysis of stemness and chemo-resistance markers.
Main Results:
- Identification of rare, non-cycling blasts in ALL.
- These blasts exhibit combined phenotypes of dormancy, stemness, and chemo-resistance.
- A novel in vivo model for dormant blasts was established.
Conclusions:
- Rare, non-cycling blasts in ALL possess unique characteristics contributing to disease persistence.
- The novel in vivo model facilitates the study of the leukemic niche.
- This research paves the way for developing new therapies targeting the leukemic microenvironment and dormant cells.
Related Concept Videos
Treatment Resistant Cancers
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Drugs that Stabilize Microtubules


